Triprolidine
From Wikipedia, the free encyclopedia
Triprolidine
|
|
Systematic (IUPAC) name | |
2-[(E)-1-(4-methylphenyl)-3-pyrrolidin-1-yl- prop-1-enyl]pyridine |
|
Identifiers | |
CAS number | |
ATC code | R06 |
PubChem | |
DrugBank | |
Chemical data | |
Formula | C19H22N2 |
Mol. mass | 278.391 g/mol |
SMILES | & |
Physical data | |
Melt. point | 60 °C (140 °F) |
Solubility in water | 500 mg/mL (20 °C) |
Pharmacokinetic data | |
Bioavailability | 4% oral |
Protein binding | 90% |
Metabolism | Hepatic (CYP2D6) |
Half life | 4 to 6 hours |
Excretion | Renal |
Therapeutic considerations | |
Pregnancy cat. |
C (US) |
Legal status |
OTC (US) |
Routes | Oral |
Triprolidine hydrochloride is an over-the-counter antihistamine. It is used to combat the symptoms associated with allergies and is sometimes combined with other cold medications designed to provide general relief for flu-like symptoms. Like many over-the-counter antihistamines, the most common side effect is drowsiness.
[edit] Trade names
- Actidil
- Myidil
- Actifed (as a combination with pseudoephedrine)
Note: in some countries (Belgium e.g.), ACTIFED contains pseudoephedrine and triprolidine, but the same pharmaceutical company (GSK) has introduced an "ACTIFED New" which contains dextromethorphan hydrobromide, an anti-tussive compound unrelated to pseudoephedrine and triprolidine, and with different indications (symptomatic treatment of non-productive, irritative cough).
[edit] External links
|